1
|
Stammler B, Flammer K, Schuster T, Lambert M, Neumann O, Lux M, Matuz T, Karnath HO. Spatial Neglect Therapy With the Augmented Reality App "Negami" for Active Exploration Training: A Randomized Controlled Trial on 20 Stroke Patients With Spatial Neglect. Arch Phys Med Rehabil 2023; 104:1987-1994. [PMID: 37582475 DOI: 10.1016/j.apmr.2023.07.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Revised: 07/27/2023] [Accepted: 07/28/2023] [Indexed: 08/17/2023]
Abstract
OBJECTIVE To investigate the efficacy of the augmented reality (AR) app "Negami" as an active exploration training for the treatment of spatial neglect. Improvements of the ipsilesional attention and orientation bias (and resulting contralesional neglect) will be examined in stroke patients with spatial neglect and compared with a control group. DESIGN Randomized controlled trial with an experimental Negami group, consisting of patients with spatial neglect, and a group of neglect patients receiving standard neglect therapy. SETTING Three rehabilitation hospitals. PARTICIPANTS Twenty right hemispheric stroke patients with spatial neglect (N=20). INTERVENTION Over a period of 2 weeks, both groups received 5 training sessions per week (à 25 minutes). Neglect behavior was assessed weekly over a 5-week period, with the Negami therapy group receiving a second follow-up assessment at 1-to-2-month intervals after completion of training. MAIN OUTCOME MEASURES Letter Cancellation, Bells Test, Copying Task, Line Bisection Task, and a self-developed "Exploration Test". RESULTS Both groups improved significantly. While the Negami therapy group improved in 4 of 5 neglect tests used, the standard therapy group improved in only 1 of these tests. We observed significantly better improvement in the Negami group already after the first week of training. This difference was also significant after the end of the training as well as 1 week after the end of training and remained stable 1-2 months after the end of treatment. CONCLUSION Negami can be used as an effective alternative or addition to current standard neglect therapy, and may even be superior to it.
Collapse
Affiliation(s)
- Britta Stammler
- Center of Neurology, Division of Neuropsychology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
| | | | | | | | | | - Michael Lux
- Neurological Rehabilitation Center Quellenhof, Sana Kliniken AG, Bad Wildbad, Germany
| | - Tamara Matuz
- Center of Neurology, Division of Neuropsychology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Kreiskliniken Reutlingen, Reutlingen, Germany
| | - Hans-Otto Karnath
- Center of Neurology, Division of Neuropsychology, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
| |
Collapse
|
2
|
Thill M, Lüftner D, Kolberg-Liedtke C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Friedrich M, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Jackisch C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lux M, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Müller V, Janni W, Ditsch N. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022. Breast Care (Basel) 2022; 17:421-429. [PMID: 36156913 PMCID: PMC9453659 DOI: 10.1159/000524789] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2022] [Accepted: 04/21/2022] [Indexed: 08/03/2023] Open
Abstract
The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2022 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer.
Collapse
Affiliation(s)
- Marc Thill
- Klinik für Gynäkologie und Gynäkologische Onkologie, Agaplesion Markus Krankenhaus, Frankfurt, Germany
| | - Diana Lüftner
- Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité, Berlin, Germany
| | | | - Ute-Susann Albert
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Würzburg, Würzburg, Germany
| | - Maggie Banys-Paluchowski
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
| | - Ingo Bauerfeind
- Frauenklinik, Klinikum Landshut gemeinnützige GmbH, Landshut, Germany
| | - Jens-Uwe Blohmer
- Klinik für Gynäkologie mit Brustzentrum des Universitätsklinikums der Charite, Berlin, Germany
| | - Wilfried Budach
- Strahlentherapie, Radiologie Düsseldorf, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | - Peter Dall
- Frauenklinik, Städtisches Klinikum Lüneburg, Lüneburg, Germany
| | - Eva Maria Fallenberg
- Institut für Klinische Radiologie, Klinikum der Universität München Campus Großhadern, Munich, Germany
| | | | - Tanja Fehm
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | - Michael Friedrich
- Klinik für Frauenheilkunde und Geburtshilfe, Helios Klinikum Krefeld, Krefeld, Germany
| | - Bernd Gerber
- Universitätsfrauenklinik und Poliklinik am Klinikum Südstadt, Rostock, Germany
| | - Oleg Gluz
- Brustzentrum, Evang, Krankenhaus Bethesda, Mönchengladbach, Germany
| | - Nadia Harbeck
- Brustzentrum, Klinik für Gynäkologie und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität, München, Germany
| | - Jörg Heil
- Klinik für Frauenheilkunde und Geburtshilfe, Sektion Senologie, Universitäts-Klinikum Heidelberg, Heidelberg, Germany
| | - Jens Huober
- Brustzentrum, Kantonspital St. Gallen, St. Gallen, Switzerland
| | - Christian Jackisch
- Klinik für Gynäkologie und Geburtshilfe, Sana Klinikum Offenbach, Offenbach, Germany
| | | | - David Krug
- Klinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Thorsten Kühn
- Klinik für Frauenheilkunde und Geburtshilfe, Klinikum Esslingen, Esslingen, Germany
| | - Sherko Kümmel
- Klinik für Senologie, Evangelische Kliniken Essen Mitte, Essen, Germany
| | - Sibylle Loibl
- German Breast Group Forschungs GmbH, Frankfurt, Germany
| | - Michael Lux
- Kooperatives Brustzentrum Paderborn, Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn und St. Josefs-Krankenhaus, Paderborn, Germany
| | - Nicolai Maass
- St. Vincenz-Krankenhaus GmbH, Paderborn, Germany
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Christoph Mundhenke
- Klinik für Gynäkologie und Geburtshilfe, Klinikum Bayreuth, Bayreuth, Germany
| | - Ulrike Nitz
- Brustzentrum, Evang, Krankenhaus Bethesda, Mönchengladbach, Germany
| | - Tjoung-Won Park-Simon
- Klinik für Frauenheilkunde und Geburtshilfe, Medizinische Hochschule Hannover, Hanover, Germany
| | - Toralf Reimer
- Universitätsfrauenklinik und Poliklinik am Klinikum Südstadt, Rostock, Germany
| | - Kerstin Rhiem
- Zentrum Familiärer Brust- und Eierstockkrebs, Universitätsklinikum Köln, Cologne, Germany
| | - Achim Rody
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
| | - Marcus Schmidt
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit der Johannes-Gutenberg-Universität Mainz, Mainz, Germany
| | - Andreas Schneeweiss
- Nationales Centrum für Tumorerkrankungen, Universitätsklinikum und Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Florian Schütz
- Klinik für Gynäkologie und Geburtshilfe, Diakonissen Krankenhaus Speyer, Speyer, Germany
| | - Hans-Peter Sinn
- Sektion Gynäkopathologie, Pathologisches Institut, Universitätsklinikum Heidelberg, Heidelberg, Germany
| | - Christine Solbach
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Frankfurt, Frankfurt, Germany
| | - Erich-Franz Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany
| | - Elmar Stickeler
- Klinik für Gynäkologie und Geburtsmedizin, Universitätsklinikum Aachen, Aachen, Germany
| | - Christoph Thomssen
- Universitätsfrauenklinik, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany
| | - Michael Untch
- Klinik für Gynäkologie und Geburtshilfe, Helios Klinikum Berlin-Buch, Berlin, Germany
| | - Isabell Witzel
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - Achim Wöckel
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Würzburg, Würzburg, Germany
| | - Volkmar Müller
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - Wolfgang Janni
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany
| | - Nina Ditsch
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Augsburg, Augsburg, Germany
| |
Collapse
|
3
|
Kolberg-Liedtke C, Schumacher J, Erber R, Braun M, Heinrich B, Hoffmann O, Fasching P, Forstbauer H, Kleine-Tebbe A, Kunz G, Lux M, Rom J, Schem C, Stahl N, Hartmann A, Kasimir-Bauer S, Kolberg HC. Abstract OT2-29-01: neoMono - An adaptive randomized neoadjuvant two arm trial in patients with TNBC comparing a mono atezolizumab window followed by atezolizumab and chemotherapy with atezolizumab and chemotherapy. Cancer Res 2022. [DOI: 10.1158/1538-7445.sabcs21-ot2-29-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Improvement of systemic treatment of TNBC represents an unmet medical need. Recently, targeted therapy of regulatory immune pathways has become an important option in the treatment of numerous malignancies including breast cancer. Neoadjuvant trials combining chemotherapy and checkpoint inhibitors (KEYNOTE-522 and IMPASSION031) have demonstrated a meaningful benefit regarding pathological complete remission (pCR) and event-free survival (EFS) for the addition of PD-1- and PD-L1-inhibitors to chemotherapy among patients with TNBC, respectively. In addition, initial analyzes have presented promising results regarding event-free survival. In the neoadjuvant GeparNuevo trial only a subgroup of patients with TNBC, receiving a 2-week checkpoint inhibitor monotherapy window before the start of neoadjuvant chemotherapy in combination with checkpoint inhibition, achieved a pCR benefit as compared to patients treated with neoadjuvant chemotherapy alone. Trial Design: NeoMono is a phase 2 randomized multicenter trial recruiting male and female patients with primary TNBC (defined as ER/PR < 10% and HER2 negative). Neoadjuvant treatment in Arm A and B consists of Atezolizumab 1200 mg every 3 weeks in addition to neoadjuvant chemotherapy (i.e. 12 x Carboplatin and Paclitaxel q1w followed by Epirubicin and Cyclophosphamide q3w) In Arm A this therapy is preceded by Atezolizumab 840 mg q2w (Atezolizumab mono window). Study goals are the comparison of efficacy and safety of neoadjuvant chemotherapy with Atezolizumab with and without Atezolizumab two-week window (primary endpoint: pCR) and the identification of biomarkers predicting (early) response to or resistance against Atezolizumab. The broad translational program of the neoMono trial aims at identifying these biomarkers on tumor and patient level. The neoMono statistical design adapts the idea of a proof-of-concept trial and uses Bayesian posterior and predictive probabilities for inference about the primary hypothesis. Up to four planned efficacy interim analyses provide decision points for early stopping for success or futility. The expected maximum number of patients to be recruited is 458.
Citation Format: Cornelia Kolberg-Liedtke, Johannes Schumacher, Ramona Erber, Michael Braun, Bernhard Heinrich, Oliver Hoffmann, Peter Fasching, Helmut Forstbauer, Anke Kleine-Tebbe, Georg Kunz, Michael Lux, Joachim Rom, Christian Schem, Nicole Stahl, Arndt Hartmann, Sabine Kasimir-Bauer, Hans-Christian Kolberg. neoMono - An adaptive randomized neoadjuvant two arm trial in patients with TNBC comparing a mono atezolizumab window followed by atezolizumab and chemotherapy with atezolizumab and chemotherapy [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr OT2-29-01.
Collapse
Affiliation(s)
| | | | - Ramona Erber
- Institute of Pathology, University Hospital Erlangen, Erlangen, Germany
| | | | | | | | | | | | | | - Georg Kunz
- St. Johannes Spital Dortmund, Dortmund, Germany
| | | | | | | | | | - Arndt Hartmann
- University of Erlangen, Institute of Pathology, Erlangen, Germany
| | | | | |
Collapse
|
4
|
Boscary J, Schauer F, Ghidersa BE, Krüßmann R, Lux M, Czerwinski M, Wang Z, Li C, Mendelevitch B, Ehrke G. Thermal loading test of a Wendelstein 7-X pumping gap panel. Fusion Engineering and Design 2022. [DOI: 10.1016/j.fusengdes.2021.112986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
5
|
Mahtani R, Niyazov A, Lewis MPHK, Massey L, Rider A, Arondekar B, Lux M. HSR21-062: Real-World Study of BRCA1/2 Mutation (BRCA1/2mut) Testing Among Adult Patients (pts) With HER2− Advanced Breast Cancer (ABC) in the US. J Natl Compr Canc Netw 2021. [DOI: 10.6004/jnccn.2020.7760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Reshma Mahtani
- 1Sylvester Cancer Center, University of Miami, Deerfield Beach, FL
| | | | | | | | | | | | - Michael Lux
- 4Kooperatives Brustzentrum Paderborn; Frauenklinik St. Louise, Paderborn; St. Josefs-Krankenhaus, Salzkotten; and Frauen- und Kinderklinik St. Louise, Paderborn, Germany
| |
Collapse
|
6
|
Lux M, Niyazov A, Lewis K, Massey L, Rider A, Arondekar B, Mahtani R. HSR21-061: Frequency of Oncologists (ONC) Office Visit and Caregiver Burden With Poly(ADP-ribose) Polymerase Inhibitor (PARPi) Versus Chemotherapy (CTX) Among Adult Patients (pts) With Germline BRCA1/2 Mutated (gBRCA1/2mut) HER2- Advanced Breast Cancer (ABC): Results From a Multi-Country Real-World (RW) Study. J Natl Compr Canc Netw 2021. [DOI: 10.6004/jnccn.2020.7761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Michael Lux
- 1Kooperatives Brustzentrum Paderborn; Frauenklinik St. Louise, Paderborn; St. Josefs-Krankenhaus, Salzkotten; and Frauen- und Kinderklinik St. Louise, Paderborn, Germany
| | | | | | | | | | | | - Reshma Mahtani
- 5Sylvester Cancer Center, University of Miami, Deerfield Beach, FL
| |
Collapse
|
7
|
Ditsch N, Untch M, Kolberg-Liedtke C, Jackisch C, Krug D, Friedrich M, Janni W, Müller V, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Diel I, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Hanf V, Harbeck N, Heil J, Huober J, Kreipe HH, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux M, Maass N, Moebus V, Mundhenke C, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Witzel I, Wöckel A, Thill M. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020. Breast Care (Basel) 2020; 15:294-309. [PMID: 32774225 DOI: 10.1159/000508736] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Accepted: 05/08/2020] [Indexed: 11/19/2022] Open
Affiliation(s)
- Nina Ditsch
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Augsburg, Augsburg, Germany
| | - Michael Untch
- Klinik für Gynäkologie und Geburtshilfe, Helios Klinikum Berlin-Buch, Berlin, Germany
| | | | - Christian Jackisch
- Klinik für Gynäkologie und Geburtshilfe, Sana Klinikum Offenbach, Offenbach, Germany
| | - David Krug
- Klinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Michael Friedrich
- Klinik für Frauenheilkunde und Geburtshilfe, Helios Klinikum Krefeld, Krefeld, Germany
| | - Wolfgang Janni
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany
| | - Volkmar Müller
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - Ute-Susann Albert
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Würzburg, Würzburg, Germany
| | | | - Ingo Bauerfeind
- Frauenklinik, Klinikum Landshut gemeinnützige GmbH, Landshut, Germany
| | - Jens-Uwe Blohmer
- Klinik für Gynäkologie mit Brustzentrum des Universitätsklinikums der Charité, Berlin, Germany
| | - Wilfried Budach
- Strahlentherapie, Radiologie Düsseldorf, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | - Peter Dall
- Frauenklinik, Städtisches Klinikum Lüneburg, Lüneburg, Germany
| | - Ingo Diel
- Praxisklinik am Rosengarten, Mannheim, Germany
| | - Eva Maria Fallenberg
- Institut für Klinische Radiologie, Klinikum der Universität München, Campus Grosshadern, Munich, Germany
| | | | - Tanja Fehm
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | - Bernd Gerber
- Universitätsfrauenklinik am Klinikum Südstadt, Klinikum Südstadt Rostock, Rostock, Germany
| | - Oleg Gluz
- Ev. Krankenhaus Bethesda Brustzentrum, Mönchengladbach, Germany
| | - Volker Hanf
- Frauenklinik Nathanstift (Brustzentrum und Gynäkologisches Krebszentrum, Klinikum Fürth, Fürth, Germany
| | - Nadia Harbeck
- Brustzentrum, Klinik für Gynäkologie und Geburtshilfe, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany
| | - Jörg Heil
- Universitäts-Klinikum Heidelberg Brustzentrum, Heidelberg, Germany
| | - Jens Huober
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany
| | - Hans H Kreipe
- Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany
| | - Thorsten Kühn
- Klinik für Frauenheilkunde und Geburtshilfe, Klinikum Esslingen, Esslingen, Germany
| | | | - Sibylle Loibl
- German Breast Group Forschungs GmbH, Neu-Isenburg, Germany
| | - Diana Lüftner
- Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité, Berlin, Germany
| | - Michael Lux
- Klinik für Gynäkologie und Geburtshilfe, St. Vinzenz-Krankenhaus GmbH Paderborn, Paderborn, Germany
| | - Nicolai Maass
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Volker Moebus
- Klinik für Gynäkologie und Geburtshilfe, Klinikum Frankfurt Höchst GmbH, Frankfurt, Germany
| | - Christoph Mundhenke
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - Tjoung-Won Park-Simon
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Hannover, Hannover, Germany
| | - Toralf Reimer
- Universitätsfrauenklinik am Klinikum Südstadt, Klinikum Südstadt Rostock, Rostock, Germany
| | - Kerstin Rhiem
- Zentrum Familiärer Brust- und Eierstockkrebs, Universitätsklinikum Köln, Cologne, Germany
| | - Achim Rody
- Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
| | - Marcus Schmidt
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Johannes-Gutenberg-Universität Mainz, Mainz, Germany
| | | | - Chistine Solbach
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Frankfurt, Frankfurt, Germany
| | - Erich-Franz Solomayer
- Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
| | - Elmar Stickeler
- Klinik für Gynäkologie und Geburtsmedizin, Universitätsklinikum Aachen, Aachen, Germany
| | - Christoph Thomssen
- Universitätsfrauenklinik, Martin-Luther-Universität Halle-Wittenberg, Halle/Saale, Germany
| | - Isabell Witzel
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
| | - Achim Wöckel
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Würzburg, Würzburg, Germany
| | - Marc Thill
- Klinik für Gynäkologie und Gynäkologische Onkologie, Agaplesion Markus Krankenhaus, Frankfurt, Germany
| |
Collapse
|
8
|
Eichler C, Paepke S, Ohlinger R, Mathias W, Scheffen I, Lux M, Hadad S, Kiernan T, Whisker L, Kaushik M, King P. Abstract P2-14-05: Can an internal surgical adhesive facilitate drain-free mastectomy and reduce overall invasiveness?-A prospective, randomized, controlled, multicenter non-inferiority trial. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p2-14-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Mastectomy closure without drains has many potential advantages. Flap fixation techniques have shown to be an effective alternative to drains. This study tested the non-inferiority of a surgical adhesive in overall invasiveness compared to standard wound closure with drains. Methods: This trial (ClinicalTrials.gov Identifier: NCT02958449) recruited seventy-seven patients undergoing eighty-four mastectomies +/- SLNB (n=84) at eleven international centers. Procedures were prospectively randomized to standard wound closure with drains (SWC; n=41) or wound closure without drains using a high strength lysine-based adhesive named TissuGlu® (TG; n= 43). The primary outcome measured assessed overall invasiveness using the number of post-operative clinical interventions, including drain removals and needle aspirations. Secondary endpoints included total wound drainage, cumulative days of treatment, days to drain removal and wound healing related complications. A patient questionnaire evaluating quality of life measures was also administered. Results: Subjects in the TissuGlu® group required significantly fewer post-operative clinical interventions (1.25 ± 1.39 TG vs. 2.03 ± 1.45 SWC, p = <.0001) compared to the Control group and had fewer cumulative days of treatment (defined as days of drains being in place and / or days on which an aspiration occurred; 2.14 ± 4.15 TG vs. 5.76 ± 4.02 SWC, p = <0.0001). Presence of a drain was associated with significantly higher pain and lower mobility scores. Conclusion: The study demonstrates that flap fixation with this adhesive can permit drain-free mastectomy closure, reducing overall invasiveness and patient morbidity.
Citation Format: Eichler C, Paepke S, Ohlinger R, Mathias W, Scheffen I, Lux M, Hadad S, Kiernan T, Whisker L, Kaushik M, King P. Can an internal surgical adhesive facilitate drain-free mastectomy and reduce overall invasiveness?-A prospective, randomized, controlled, multicenter non-inferiority trial [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-14-05.
Collapse
Affiliation(s)
- C Eichler
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - S Paepke
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - R Ohlinger
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - W Mathias
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - I Scheffen
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - M Lux
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - S Hadad
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - T Kiernan
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - L Whisker
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - M Kaushik
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| | - P King
- Kliniken der Stadt Köln, Brustzentrum, Köln, Germany; St. Elisabeth Krankenhaus, Brustzentrum, Köln, Köln, Germany; Universitätsklinikum Erlangen, Frauenklinik, Erlangen, Erlangen, Germany; Universitätsklinik Greifswald, Interdisziplinäres Brustzentrum, Greifswald, Greifswald, Germany; University Hospitals of Leicester, Leicester, Leicester, United Kingdom; Royal Cornwall Hospital, Cornwall, Cornwall, United Kingdom; Klinik und Poliklinik für Frauenheilkunde Technische Universität München, Brustzentrum, München, Germany; Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom; St. Helens and Knowsley Teaching Hospitals, St. Helens, St. Helens, United Kingdom; Nottingham University Hospitals, Nottingham, Nottingham, United Kingdom
| |
Collapse
|
9
|
Iakovidou C, Anagnostopoulos N, Lux M, Christodoulou K, Boutalis Y, Chatzichristofis SA. Composite description based on Salient Contours and Color information for CBIR tasks. IEEE Trans Image Process 2019; 28:3115-3129. [PMID: 30703019 DOI: 10.1109/tip.2019.2894281] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
This paper introduces a novel image descriptor for content based image retrieval tasks that integrates contour and color information into a compact vector. Loosely inspired by the human visual system and its mechanisms in efficiently identifying visual saliency, operations are performed on a fixed lattice of discrete positions by a set of edge detecting kernels that calculate region derivatives at different scales and orientation. The description method utilizes a weighted edge histogram where bins are populated on the premise of whether the regions contain edges belonging to the salient contours, while the discriminative power is further enhanced by integrating regional quantized color information. The proposed technique is both efficient and adaptive to the specifics of each depiction, while it does not need any training data to adjust parameters. Experimental evaluation conducted on seven benchmarking datasets against 13 well known global descriptors along with SIFT, SURF implementations (both in VLAD and BOVW), highlight the effectiveness and efficiency of the proposed descriptor.
Collapse
|
10
|
Dittrich R, Kliesch S, Schüring A, Balcerek M, Baston-Büst DM, Beck R, Beckmann MW, Behringer K, Borgmann-Staudt A, Cremer W, Denzer C, Diemer T, Dorn A, Fehm T, Gaase R, Germeyer A, Geue K, Ghadjar P, Goeckenjan M, Götte M, Guth D, Hauffa BP, Hehr U, Hetzer F, Hirchenhain J, Hoffmann W, Hornemann B, Jantke A, Kentenich H, Kiesel L, Köhn FM, Korell M, Lax S, Liebenthron J, Lux M, Meißner J, Micke O, Nassar N, Nawroth F, Nordhoff V, Ochsendorf F, Oppelt PG, Pelz J, Rau B, Reisch N, Riesenbeck D, Schlatt S, Sender A, Schwab R, Siedentopf F, Thorn P, Wagner S, Wildt L, Wimberger P, Wischmann T, von Wolff M, Lotz L. Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women. Geburtshilfe Frauenheilkd 2018; 78:567-584. [PMID: 29962516 PMCID: PMC6018069 DOI: 10.1055/a-0611-5549] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2018] [Revised: 04/15/2018] [Accepted: 04/17/2018] [Indexed: 12/17/2022] Open
Abstract
Aim
The aim of this official guideline published by the German Society of Gynecology and Obstetrics (DGGG) and coordinated with the German Society of Urology (DGU) and the German Society of Reproductive Medicine (DGRM) is to provide consensus-based recommendations, obtained by evaluating the relevant literature, on counseling and fertility preservation for prepubertal girls and boys as well as patients of reproductive age. Statements and recommendations for girls and women are presented below. Statements or recommendations for boys and men are not the focus of this guideline.
Methods
This S2k guideline was developed at the suggestion of the guideline commission of the DGGG, DGU and DGRM and represents the structured consensus of representative members from various professional associations (n = 40).
Recommendations
The guideline provides recommendations on counseling and fertility preservation for women and girls which take account of the patientʼs personal circumstances, the planned oncologic therapy and the individual risk profile as well as the preferred approach for selected tumor entities.
Collapse
Affiliation(s)
- Ralf Dittrich
- Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Sabine Kliesch
- Centrum für Reproduktionsmedizin und Andrologie, Universitätsklinik Münster, Münster, Germany
| | | | - Magdalena Balcerek
- Pädiatrie mit Schwerpunkt Onkologie und Hämatologie, Charité Berlin, Berlin, Germany
| | | | | | - Matthias W Beckmann
- Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
| | | | - Anja Borgmann-Staudt
- Pädiatrie mit Schwerpunkt Onkologie und Hämatologie, Charité Berlin, Berlin, Germany
| | | | - Christian Denzer
- Kinder- und Jugendmedizin, Universitätsklinikum Ulm, Ulm, Germany
| | - Thorsten Diemer
- Klinik und Poliklinik für Urologie, Kinderurologie und Andrologie, Universitätsklinikum Gießen, Gießen, Germany
| | - Almut Dorn
- Praxis für Gynäkologische Psychosomatik, Hamburg, Germany
| | - Tanja Fehm
- Frauenklinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | - Rüdiger Gaase
- Gemeinschaftspraxis für Frauenheilkunde, Worms, Germany
| | - Ariane Germeyer
- Frauenklinik, Universitätsklinikum Heidelberg, Heidelberg, Germany
| | - Kristina Geue
- Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig, Leipzig, Germany
| | - Pirus Ghadjar
- Radioonkologie und Strahlentherapie, Charité Berlin, Berlin, Germany
| | | | - Martin Götte
- Frauenklinik, Universitätsklinikum Münster, Münster, Germany
| | - Dagmar Guth
- Praxis für Frauenheilkunde Plauen, Plauen, Germany
| | | | - Ute Hehr
- Zentrum für Humangenetik, Universitätsklinikum Regensburg, Regensburg, Germany
| | - Franc Hetzer
- Chirurgisches Departement, Spital Linth, Uznach, Switzerland
| | - Jens Hirchenhain
- Frauenklinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
| | | | | | | | | | - Ludwig Kiesel
- Frauenklinik, Universitätsklinikum Dresden, Dresden, Germany
| | | | - Matthias Korell
- Frauenklinik, Johanna Etienne Klinikum Neuss, Neuss, Germany
| | - Sigurd Lax
- Institut für Pathologie, LKH Graz Süd-West, Graz, Austria
| | - Jana Liebenthron
- Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Bonn, Bonn, Germany
| | - Michael Lux
- Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Julia Meißner
- Hämatologie, Onkologie und Rheumatologie, Universitätsklinikum Heidelberg, Heidelberg, Germany
| | - Oliver Micke
- Strahlentherapie und Radioonkologie, Franziskus Hospital Bielefeld, Bielefeld, Germany
| | | | - Frank Nawroth
- Facharzt-Zentrum für Kinderwunsch, Pränatale Medizin, Endokrinologie und Osteologie, amedes MVZ Hamburg GmbH, Hamburg, Germany
| | - Verena Nordhoff
- Centrum für Reproduktionsmedizin und Andrologie, Universitätsklinik Münster, Münster, Germany
| | - Falk Ochsendorf
- Andrologie, Dermatologie, Venerologie und Allergologie, Universitätsklinikum Frankfurt, Frankfurt, Germany
| | - Patricia G Oppelt
- Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
| | - Jörg Pelz
- Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Würzburg, Würzburg, Germany
| | - Beate Rau
- Onkologische Chirurgie, Charité Berlin, Berlin, Germany
| | - Nicole Reisch
- Endokrinologie, Universitätsklinikum München, München, Germany
| | | | - Stefan Schlatt
- Centrum für Reproduktionsmedizin und Andrologie, Universitätsklinik Münster, Münster, Germany
| | - Annekathrin Sender
- Medizinische Psychologie und Medizinische Soziologie, Universitätsklinikum Leipzig, Leipzig, Germany
| | - Roxana Schwab
- Frauenklinik, Universitätsklinikum Mainz, Mainz, Germany
| | - Friederike Siedentopf
- Brustzentrum, Martin-Luther-Krankenhaus, Paul Gerhardt Diakonie, Berlin-Wilmersdorf, Germany
| | - Petra Thorn
- Praxis für psychosoziale Kinderwunschberatung, Paar- und Familientherapie, Mörfelden-Walldorf, Germany
| | | | - Ludwig Wildt
- Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Innsbruck, Innsbruck, Austria
| | | | - Tewes Wischmann
- Medizinische Psychologie, Universitätsklinikum Heidelberg, Heidelberg, Germany
| | - Michael von Wolff
- Gynäkologische Endokrinologie und Reproduktionsmedizin, Universitäts-Spital Bern, Bern, Switzerland
| | - Laura Lotz
- Frauenklinik, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
| |
Collapse
|
11
|
Thill M, Schmidt M, Lux M, Liedtke C, Schneeweiss A, Jackisch C. Einführung und Verwendung von biosimilaren Antikörpern in der Therapie des Mammakarzinoms. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0043-118761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Affiliation(s)
- Marc Thill
- Klinik für Gynäkologie und Geburtshilfe, AGAPLESION Markus Krankenhaus, Frankfurt am Main
| | - Marcus Schmidt
- Klinik für Geburtshilfe und Frauengesundheit, Universitätsklinikum Mainz
| | | | - Cornelia Liedtke
- Klinik für Geburtshilfe und Frauenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - Andreas Schneeweiss
- Nationales Zentrum für Tumorerkrankungen und Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Heidelberg
| | | |
Collapse
|
12
|
Loibl S, de la Pena L, Nekljudova V, Zardavas D, Michiels S, Denkert C, Rezai M, Bermejo B, Untch M, Lee SC, Turri S, Urban P, Kümmel S, Steger G, Gombos A, Lux M, Piccart MJ, Von Minckwitz G, Baselga J, Loi S. Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). Eur J Cancer 2017; 85:133-145. [PMID: 28923573 PMCID: PMC5640494 DOI: 10.1016/j.ejca.2017.08.020] [Citation(s) in RCA: 74] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2017] [Revised: 08/18/2017] [Accepted: 08/18/2017] [Indexed: 12/25/2022]
Abstract
AIM The Neoadjuvant PI3K inhibition in HER2 OverExpressing Breast cancEr (NeoPHOEBE) trial evaluated the efficacy and safety of buparlisib, a pan-phosphatidylinositol 3-kinase (PI3K) inhibitor, plus trastuzumab and paclitaxel as neoadjuvant treatment for human epidermal growth factor receptor-2 positive (HER2+) breast cancer. METHODS NeoPHOEBE was a neoadjuvant, phase II, randomised, double-blind study. Women with HER2+ breast cancer were randomised within two independent cohorts by PIK3CA mutation status and, in each cohort stratified by oestrogen receptor (ER) status to receive buparlisib or placebo plus trastuzumab (first 6 weeks) followed by buparlisib or placebo with trastuzumab and paclitaxel. Primary end-point was pathological complete response (pCR) rate; key secondary end-point was objective response rate (ORR) at 6 weeks. Exploratory end-points were evaluation of Ki67 levels and change in tumour infiltrating lymphocytes (TILs) in intermediate biopsies at day 15. RESULTS Recruitment was suspended mainly due to liver toxicity after enrolment of 50 of the planned 256 patients. In each arm (buparlisib n = 25; placebo n = 25) 21 patients (84%) had wild type PIK3CA and 4 patients (16%) had mutant PIK3CA. Overall, pCR rate was similar between buparlisib and placebo arms (32.0% versus 40%; one-sided P = 0.811). A trend towards higher ORR (68.8% versus 33.3%; P = 0.053) and a significant decrease in Ki67 (75% versus 26.7%; P = 0.021) was observed in buparlisib versus placebo arm in the ER+ subgroup (Pinteraction = 0.03). CONCLUSIONS Addition of the pan-PI3K inhibitor buparlisib to taxane-trastuzumab-based therapy in HER2+ early breast cancer was not feasible. However, the higher ORR and Ki67 reduction in the ER+, HER2+ subgroup indicates a potential role for PI3K-targeted therapy in this setting and may warrant further investigation with better-tolerated second-generation PI3K inhibitors. TRIAL REGISTRATION IDENTIFIER NCT01816594.
Collapse
Affiliation(s)
- Sibylle Loibl
- German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany.
| | | | | | | | - Stefan Michiels
- Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France
| | - Carsten Denkert
- Institute of Pathology, Charité University Hospital, Berlin, Germany
| | | | | | - Michael Untch
- Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany
| | - Soo Chin Lee
- Department of Haematology-Oncology, National University Cancer Institute, Singapore
| | | | | | | | - Guenther Steger
- Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria
| | - Andrea Gombos
- Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium
| | - Michael Lux
- University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany
| | - Martine J Piccart
- Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium
| | | | - José Baselga
- SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA
| | - Sherene Loi
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia.
| |
Collapse
|
13
|
Lux M, Schrauder M, Hildebrandt T, Nabieva N, Kümmel S, Blohmer JU. Comparative budget impact assessment of the different breast cancer genomic tests in Germany. Breast 2017. [DOI: 10.1016/s0960-9776(17)30327-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
14
|
Weistroffer E, Vidal B, Lux M. Comparaison de deux automates de préparation de perfusions de nutrition parentérale. NUTR CLIN METAB 2017. [DOI: 10.1016/j.nupar.2016.10.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Edrich T, Dünser MW, Lux M, Schaubmair H, Bacher B, Butturini E, Dinges C, Kesner KL, Davidson MJ. CASE 11--2015: Intraoperative Transthoracic Cardiac and Pulmonary Ultrasonography. J Cardiothorac Vasc Anesth 2015; 29:1702-11. [PMID: 26298736 DOI: 10.1053/j.jvca.2015.04.032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/16/2014] [Indexed: 01/09/2023]
Affiliation(s)
- Thomas Edrich
- Department of Anesthesiology, Perioperative Medicine and General Intensive Care, Medicine.
| | - Martin W Dünser
- Department of Anesthesiology, Perioperative Medicine and General Intensive Care, Medicine
| | - Michael Lux
- Department of Anesthesiology, Perioperative Medicine and General Intensive Care, Medicine
| | - Hermann Schaubmair
- Department of Anesthesiology, Perioperative Medicine and General Intensive Care, Medicine
| | - Bernhard Bacher
- Department of Anesthesiology, Perioperative Medicine and General Intensive Care, Medicine
| | | | - Christian Dinges
- Cardiac Surgery, Salzburg General Hospital, Paracelsus Medical University, Salzburg, Austria
| | - Kimberly L Kesner
- Department of Anesthesiology, Rush University Medical Center, Chicago, IL
| | - Michael J Davidson
- Department of Surgery, Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
| |
Collapse
|
16
|
Lux M, Koköfer A, Schreiber C, Torgersen C. Surgical Aortic Valve Replacement in an Adult Patient With Congenital Factor VII Deficiency: A Case Report of Perioperative Coagulation Management. J Cardiothorac Vasc Anesth 2014; 29:1636-8. [PMID: 25534563 DOI: 10.1053/j.jvca.2014.08.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/12/2014] [Indexed: 11/11/2022]
Affiliation(s)
- Michael Lux
- Department of Anesthesiology, Perioperative Care, and Intensive Care Medicine, Salzburg, Austria.
| | - Andreas Koköfer
- Department of Anesthesiology, Perioperative Care, and Intensive Care Medicine, Salzburg, Austria
| | - Catharina Schreiber
- Department of Cardiac Surgery, University Hospital Salzburg and Paracelsus Medical University, Salzburg, Austria
| | - Christian Torgersen
- Department of Anesthesiology, Perioperative Care, and Intensive Care Medicine, Salzburg, Austria
| |
Collapse
|
17
|
Eller A, Janka R, Lux M, Saake M, Schulz-Wendtland R, Uder M, Wenkel E. Stereotactic vacuum-assisted breast biopsy (VABB)--a patients' survey. Anticancer Res 2014; 34:3831-3837. [PMID: 24982410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
AIM To analyze how patients experience Stereotactic guided vacuum-assisted breast biopsy (VABB) both physically and mentally. PATIENTS AND METHODS Two hundred and eleven consecutive women underwent VABB using one of two different biopsy devices (ATEC® and Mammotome®). Patients were queried using a questionnaire. RESULTS One hundred and eighty-nine patients were included. 90% would again prefer VABB over a surgical biopsy. Average grading for the condition during the procedure was 2.5 (very good to good) and 2.1 (very good) for the condition the week following VABB. Minor complications were mentioned in 37%. (>90% pain and hematoma). 97% of the women were satisfied by the cosmetic results. Patients with malignant histology and younger age experienced the procedure significantly worse. A significant higher rate of minor complications was found in younger patients and in the ATEC® group. CONCLUSION VABB is a physical and mental stressor to the women. Nonetheless, the majority of women indeed prefer the VABB.
Collapse
Affiliation(s)
- Achim Eller
- Department of Radiology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Rolf Janka
- Department of Radiology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Michael Lux
- Department of Gynecology and Obstetrics, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Marc Saake
- Department of Radiology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Rüdiger Schulz-Wendtland
- Department of Radiology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Michael Uder
- Department of Radiology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Evelyn Wenkel
- Department of Radiology, University Hospital Erlangen, University of Erlangen-Nuremberg, Erlangen, Germany
| |
Collapse
|
18
|
Lux M, Hildebrandt T, Beyer-Finkler E, Bani M, Loehberg C, Jud S, Rauh C, Schrauder M, Fasching P, Beckmann M. Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients. ACTA ACUST UNITED AC 2014; 8:15-21. [PMID: 24715838 DOI: 10.1159/000347098] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Breast cancer centres - certified in accordance with the criteria of the German Cancer Association and the German Mastology Association - are established throughout Germany. Although the setting up of centres and the subsequent need for certification are associated with a marked increase in costs, initial data show positive effects on quality. Certified centres are cost-effective from the point of view of health economics - they lead to improved quality in processes and results without creating any increase in costs for the funding bodies. However, the organization of the necessary structures, with interdisciplinary treatment, documentation and quality-assurance measures, requires considerable resources. Increasing consolidation of inpatient services is also involved, while shortening of the patients' hospitalization periods is leading to reduced remuneration from the funding bodies. The current cost deficits, which have resulted from the increased resources required, need to be recouped through additional charges. It will only be possible to maintain the high quality achieved if additional charges become available to cover the centres' added costs. Good data are increasingly becoming available as a basis for negotiations on charges - e.g., with regard to the quality of results and the National Cancer Plan - as well as clear support from patients.
Collapse
Affiliation(s)
- Michael Lux
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Thomas Hildebrandt
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | | | - Mayada Bani
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Christian Loehberg
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Sebastian Jud
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Claudia Rauh
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Michael Schrauder
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Peter Fasching
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| | - Matthias Beckmann
- University Breast Centre for Franconia, Department of Gynaecology, Erlangen University Hospital, Erlangen, Germany
| |
Collapse
|
19
|
Grischke EM, Wallwiener D, Souchon R, Fehm T, Loehberg C, Jud S, Lux M, Beckmann M, Renner S. Isolated Loco-Regional Recurrence of Breast Cancer - Established and Innovative Therapy Concepts. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0032-1328660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- E.-M. Grischke
- Dept. of OB/Gyn, University Hospital of Tübingen, Tübingen
| | - D. Wallwiener
- Dept. of OB/Gyn, University Hospital of Tübingen, Tübingen
| | - R. Souchon
- Dept. of Radiotherapy, University Hospital of Tübingen, Tübingen
| | - T. Fehm
- Dept. of OB/Gyn, University Hospital of Düsseldorf, Düsseldorf
| | - C. Loehberg
- Dept. of OB/Gyn, University Hospital of Erlangen, Erlangen
| | - S. Jud
- Dept. of OB/Gyn, University Hospital of Erlangen, Erlangen
| | - M. Lux
- Dept. of OB/Gyn, University Hospital of Erlangen, Erlangen
| | - M. Beckmann
- Dept. of OB/Gyn, University Hospital of Erlangen, Erlangen
| | - S. Renner
- Dept. of OB/Gyn, University Hospital of Erlangen, Erlangen
| |
Collapse
|
20
|
Lux M, Hildebrandt T, Bani M, Loehberg C, Schrauder M, Rauh C, Jud S, Fasching P, Hartmann A, Beckmann M. Health Economic Evaluation of Different Decision Aids for the Individualised Treatment of Patients with Breast Cancer. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0032-1328627] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- M. Lux
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - T. Hildebrandt
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - M. Bani
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - C. Loehberg
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - M. Schrauder
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - C. Rauh
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - S. Jud
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - P. Fasching
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - A. Hartmann
- Institute of Pathology, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| | - M. Beckmann
- Frauenklinik, Universitätsklinikum Erlangen, Universitäts-Brustzentrum CCC ER-EMN, Erlangen
| |
Collapse
|
21
|
Lux M, Maass N, Schütz F, Schwidde I, Fasching P, Fehm T, Janni W, Kümmel S, Kolberg HC, Lüftner D. Breast Cancer 2013 - Interpretation of New and Known Data. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0032-1328691] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- M. Lux
- Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen
| | - N. Maass
- Department of Gynecology and Obstetrics, University Hospital Aachen, Aachen
| | - F. Schütz
- Frauenklinik, Universitätsklinikum Heidelberg, Heidelberg
| | - I. Schwidde
- Klinik für Senologie, Kliniken Essen Mitte, Essen
| | - P. Fasching
- Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen
| | - T. Fehm
- Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich Heine Universität Düsseldorf, Düsseldorf
| | - W. Janni
- Frauenklinik, Klinikum der Universität Ulm, Ulm
| | - S. Kümmel
- Klinik für Senologie, Kliniken Essen Mitte, Essen
| | - H.-C. Kolberg
- Klinik für Gynäkologie und Geburtshilfe, Marienhospital Bottrop, Bottrop
| | - D. Lüftner
- Medizinische Klinik und Poliklinik II, Campus Charité Mitte, Berlin
| |
Collapse
|
22
|
Hüttner N, Loehberg C, Lux M, Beckmann M. Onkologische Therapien und Haarverlust. Geburtshilfe Frauenheilkd 2012. [DOI: 10.1055/s-0032-1327778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- N. Hüttner
- Frauenklinik des Universitätsklinikums Erlangen
| | - C. Loehberg
- Frauenklinik des Universitätsklinikums Erlangen
| | - M. Lux
- Frauenklinik des Universitätsklinikums Erlangen
| | - M. Beckmann
- Frauenklinik des Universitätsklinikums Erlangen
| |
Collapse
|
23
|
Goecke T, Lux M, Beckmann M, Faschingbauer F. Stammzellen aus Nabelschnurblut. Öffentliche Stammzellbanken vs. private Einlagerung. Geburtshilfe Frauenheilkd 2012. [DOI: 10.1055/s-0031-1298250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
24
|
Kümmel S, Kolberg H, Lüftner D, Lux M, Maass N, Schütz F, Fasching P, Fehm T, Janni W. Mammakarzinom 2011 – Neue Aspekte. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1280313] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022] Open
|
25
|
Goecke TW, Voigt F, Lux M, Spangler G, Beckmann MW, Beetz AM. The Association of Prenatal Attachment and Perinatal Factors with Pre-and Postpartum Depression in First-Time Mothers. Z Geburtshilfe Neonatol 2011. [DOI: 10.1055/s-0031-1293395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
26
|
|
27
|
Schulz-Wendtland R, Bani M, Lux M, Meier-Meitinger M, Adamietz B, Wenkel E, Schwab S, Beckmann M, Uder M. CMOS – Technologie für intraoperative digitale Präparateradiografien. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1271173] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
28
|
Beckmann M, Bader W, Bechtold I, Becker S, Bornhaupt J, Dimpfl T, Friese K, Frobenius W, Gembruch U, Grüßner S, Heer I, Kayser D, Kreienberg R, Petri E, Rimbach S, Scharl A, Schmidt S, Schwenzer T, Solomayer E, Steiner E, Strauss A, Vetter K, Wallwiener D, Lux M. Finanzierung und finanzielle Probleme von Leistungen und Strukturen im Fachgebiet Gynäkologie und Geburtshilfe im Jahr 2011 – DRG-System und stationäre Versorgung inklusive Urogynäkologie und benigner wie auch maligner gynäkologischer Operationen. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1271116] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
29
|
Beckmann M, Bader W, Bechtold I, Becker S, Bornhaupt J, Dimpfl T, Friese K, Frobenius W, Gembruch U, Grüßner S, Heer I, Kayser D, Kreienberg R, Petri E, Rimbach S, Scharl A, Schmidt S, Schwenzer T, Solomayer E, Steiner E, Vetter K, Wallwiener D, Lux M. Finanzierung und finanzielle Probleme von Leistungen und Strukturen im Fachgebiet Gynäkologie und Geburtshilfe im Jahr 2011 – allgemeine Aspekte und geburtshilfliche Versorgung. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1271117] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
30
|
Frobenius W, Cupisti S, Lux M, Hildebrandt T, Winkler M, Beckmann M. Qualitätsmanagement in der Studentenausbildung. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1271021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
31
|
Fehm T, Janni W, Kümmel S, Lüftner D, Lux M, Schütz F, Fasching P. Review: SABCS 2010 – Aktuelle Therapie der Patientin mit einem Mammakarzinom. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1271020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
32
|
Lux M. The Magic of Encounter: The Person-Centered Approach and the Neurosciences / Die Magie der Begegnung: Der Personzentrierte Ansatz und die Neurowissenschaften / La Magia del Encuentro: El enfoque centrado en la persona y las neurociencias / La Magie de la Rencontre: l'Approche Centrée sur la Personne et les Neurosciences / A Magia do Encontro: a Abordagem Centrada na Pessoa e as Neurociências /. Person-Centered & Experiential Psychotherapies 2010. [DOI: 10.1080/14779757.2010.9689072] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
33
|
Fasching P, Fehm T, Janni W, Kümmel S, Lüftner D, Lux M, Maass N. Aktuelle Therapie der Patientin mit einem Mammakarzinom. Geburtshilfe Frauenheilkd 2010. [DOI: 10.1055/s-0030-1250437] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
34
|
Lux M, Reichelt C, Wallwiener D, Kreienberg R, Jonat W, Gnant M, Beckmann M. Onkologie. Mammakarzinom: Bisphosphonate in der Adjuvanz – auch aus gesundheitsökonomischer Sicht eine sinnvolle Therapie. Geburtshilfe Frauenheilkd 2010. [DOI: 10.1055/s-0030-1250227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
35
|
Lux M, Fasching P, Bani M, Schrauder M, Loehberg C, Oppelt P, Hildebrandt T, Grün A, Beckmann M, Goecke T. Marketing von Brust- und Perinatalzentren – Sind Patientinnen mit dem Produkt „zertifiziertes Zentrum“ vertraut? Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1185549] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
36
|
Kunzmann U, Lux M, Krebs S, Thiel F, Beckmann M, Kollmannsberger B. Onkologie. Paravasatbildung bei aggressiver Chemotherapie, trotz korrekt platzierten Venenverweilkatheters. Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1185568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
37
|
Lux M, Brauch H, Fehm T, Janni W, Maass N, Rody A, Harbeck N, Niederacher D, Beckmann M, Fasching P. Pharmakogenetik in der antihormonellen Therapie von Patientinnen mit einem Mammakarzinom. Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-2008-1039205] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
38
|
Beckmann M, Bechtold I, Debus G, Feige A, Frobenius W, Kiesel L, Kunzmann U, Lux M, Sehouli J, Solomayer E, Steiner E, Wagner S, Schwenzer T, Kreienberg R, Wallwiener D. Ist die zukünftige Finanzierung von medizinischer Qualität noch gesichert? Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1185343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
39
|
Wagner S, Bani M, Fasching P, Schrauder M, Löhberg C, Beckmann M, Lux M. Ist ein Brustzentrum finanzierbar? – Berechnung einzelner Leistungen am Beispiel des Universitäts-Brustzentrums Franken (UBF). Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-2008-1039170] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
40
|
Beckmann M, Bechtold I, Debus G, Feige A, Frobenius W, Kiesel L, Kunzmann U, Lux M, Sehouli J, Solomayer E, Steiner E, Wagner S, Schwenzer T, Kreienberg R, Wallwiener D. Ist die zukünftige Finanzierung von medizinischer Qualität noch gesichert? Bericht der Finanzierungskommission der DGGG e. V. – Teil I. Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-2008-1039287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
41
|
Beckmann M, Bechtold I, Debus G, Feige A, Frobenius W, Kiesel L, Kunzmann U, Lux M, Sehouli J, Solomayer E, Steiner E, Wagner S, Schwenzer T, Wallwiener D. Ist die zukünftige Finanzierung von medizinischer Qualität noch gesichert? Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-2008-1038967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
42
|
Wagner S, Ganslandt T, Keiling C, Jap D, Fasching P, Lux M, Beckmann M. Ist ein Brustzentrum finanzierbar? - Ein Kalkulationsmodell für das Universitäts-Brustzentrum Franken (UBF). Geburtshilfe Frauenheilkd 2007. [DOI: 10.1055/s-2007-965584] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
43
|
Jud S, Schrauder M, Lux M, Fasching P, Beckmann M, Löhberg C. Signalhemmer in der gynäkologischen Onkologie. Geburtshilfe Frauenheilkd 2007. [DOI: 10.1055/s-2007-965764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
44
|
Motschnig-Pitrik R, Lux M. The Person-Centered Approach Meets Neuroscience: Mutual Support for C. R. Rogers's and A. Damasio's Theories. Journal of Humanistic Psychology 2007. [DOI: 10.1177/0022167807306044] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Neuroscience offers new ways and levels to look into the functioning of our organisms. It thus can be used as a means to confirm or question psychological phenomena. In this article, the authors aim to view Carl Rogers's theory of personality and behavior in light of Antonio Damasio's theories and hypotheses concerning emotions, feelings, and conscious thought. The results indicate a tight correspondence of basic concepts and hypotheses such as the actualizing tendency and the vital role of feelings in thought. Furthermore, several ways accrue in which neuroscience and psychology complement one another in producing a more complete and, hence, reliable image of human functioning.
Collapse
Affiliation(s)
| | - Michael Lux
- neurological rehabilitation center in Bad Wildbad, Germany
| |
Collapse
|
45
|
Koch A, Raidl M, Lux M, Müller K, Büning H, Humme S, Erdmann E. IL-12-induced T-bet expression and IFNgamma release in lymphocytes from asthmatics--role of MAPkinases ERK-1/-2, p38(MAPK) and effect of dexamethasone. Respir Med 2006; 101:1321-30. [PMID: 17127048 DOI: 10.1016/j.rmed.2006.10.010] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2006] [Revised: 06/22/2006] [Accepted: 10/06/2006] [Indexed: 12/20/2022]
Abstract
The transcription factor T-box-expressed-in-T-cells (T-bet) is required for T(H)1 lymphocyte differentiation, regulates the IL-12-induced expression of the T(H)1-specific cytokine IFNgamma and may be dysregulated in asthmatics. The modulatory role of extracellular signal-regulated kinase (ERK)-1/-2, p38mitogen-activated protein kinase (MAPK) and dexamethasone on IL-12 induced T-bet and IFNgamma expression was assessed in peripheral blood lymphocytes of 10 atopic asthmatics and 10 nonatopic normals. IFNgamma production was dependent on phosphorylation of ERK-1/-2 and p38MAPK, as examined by PD098059, an inhibitor of the upstream activator of MAPKkinase (MKK-1), and SB203580, an inhibitor of p38MAPK. The inhibitory effect of PD098059 on IFNgamma release was decreased in asthmatic T-cells compared with normals. The IL-12-induced T-bet expression and the inhibitory effect of SB203580 were increased in asthmatic T-cells compared with normals. Dexamethasone blocked the IL-12-induced T-bet expression in asthmatic T-cells completely and decreased IL-12-induced IFNgamma release by approximately 50%, which occurred to the same extent in asthmatic and normal T-cells. In conclusion, (1) p38MAPK-pathway rather than ERK-pathway may play a more basic role in the regulation of the increased T-bet expression in asthma, and (2) ERK- and p38MAPK-activation modulate IFNgamma expression independently of T-bet and this regulatory role of ERK-1/-2 on IFNgamma release is impaired in asthma. The therapeutic benefit of dexamethasone on T-bet and IFNgamma production seems to be critical.
Collapse
Affiliation(s)
- Andrea Koch
- Department of Pneumology, University of Cologne, Medical Clinic III, Joseph-Stelzmann-Strasse 9, 50924 Köln (Cologne), Germany.
| | | | | | | | | | | | | |
Collapse
|
46
|
Twieg R, Ebert M, Jungbauer D, Lux M, Reck B, Swalen J, Teraoka I, Willson CG, Yoon DY, Zentel R. Nonlinear Optical Epoxy Polymers with Polar Tolan Chromophores. ACTA ACUST UNITED AC 2006. [DOI: 10.1080/10587259208046870] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- R. Twieg
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - M. Ebert
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - D. Jungbauer
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - M. Lux
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - B. Reck
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - J. Swalen
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - I. Teraoka
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - C. G. Willson
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - D. Y. Yoon
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| | - R. Zentel
- a IBM Research Division Almaden Research Center , 650 Harry Road, San Jose , California , 95120-6099 , USA
| |
Collapse
|
47
|
Lux M, Loehberg C, Beckmann K, Kreis H, Bauer S, Ott O, Beckmann M, Fasching P. Fluorouracil and Mitomycin: An Option for Metastatic Breast Cancer. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-924284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
48
|
Bani M, Krainick-Strobel U, Wenkel E, Lux M, Ott O, Fasching P, Schulz-Wendtland R, Beckmann M. Gutartige und präinvasive Läsionen der Brust. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-924427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
49
|
Lux M. MIX —The first results of the ongoing prospective multicentre phase II study. J Clin Oncol 2006. [DOI: 10.1200/jco.2006.24.18_suppl.10756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
10756 Background: The treatment of patiens with metastatic breast cancer (MBC) previously treated with anthracycline represents a significant challenge. Several studies have shown that oral capecitabine is an effective and well-tolerated agent. Mitomycin C has notable therapeutic activity and presents additive effects. Primary endpoints of this ongoing prospective, multi-centre, phase II study are to evaluate the safety and efficacy of the combination. TTP and QoL are secondary endpoints. Methods: Patients receive six cycles of mitomycin C 8 mg/m2, d1, and capecitabine 2,000 mg/m2, d1–14, q21d. 46 patients are planned for treatment, 17 patients are already enrolled. Evaluation (RECIST) has to be done after the fourth and sixth cycle. Safety is evaluated in all patients. Data for 16 patients were analysed, one patient has not be monitored up to date. Results: All patients have been pre-treated with anthracyclines and 62.5% with taxanes. 68.8% had multiple sites of metastases. 6.3% received just 1 cycle, 6.3% 2, 12.5% 3, 31.3% 4 and 43.8% 6 cycles. 11.3% of the cycles received dose reduction and 12.7% interval prolongation. Following grade 3- and 4-toxicities (NCI CTC) were observed in the 71 cycles: dyspnea [3 × grade 3 and 2 × grade 4; all occurred in patients with pulmonal metastases or pleural effusions], nausea (1 × grade 3), thrombopenia (2 × grade 3), fatigue (1 × grade 3), mucositis (1 × grade 3) and hand-foot-syndrome (4 × grade 3). Best response rates were: 18.8% progressive disease, 37.5% stable disease, 31.3% partial remission and 12.5% complete remission. Conclusions: The treatment with mitomycin C and capecitabine presents a favourable safety profile, which is well tolerated and active in this setting. The safety commission recommends the continuation after revision of the preliminary data. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- M. Lux
- Universitätsfrauenklinik, Erlangen, Germany
| |
Collapse
|
50
|
Raidl M, Lux M, Müller K, Schröder T, Koch A. Einfluss der p38MAPkinase auf die T-bet-Expression und IFNy-Ausschüttung in Lymphozyten von Asthmatikern. Pneumologie 2006. [DOI: 10.1055/s-2006-933906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|